Clinical Trial Update: MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352) [Phase 3]

View source ↗

Summary

A Phase 3 trial of MK-0954A in Japanese patients with essential hypertension not adequately controlled by losartan has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MK-0954A

Snippet

Sponsor: Organon and Co | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2013-03-22